Healthcare provider profile · identity verified

Jasminka Mujcic, MD

Family Practice · PORTLAND, OR · NPI 1427461789

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	231	78
Amlodipine Besylate	Amlodipine Besylate	175	61
Lisinopril	Lisinopril	140	49
Losartan Potassium	Losartan Potassium	138	44
Rosuvastatin Calcium	Rosuvastatin Calcium	124	41
Gabapentin	Gabapentin	110	29
Trazodone Hcl	Trazodone Hcl	104	31
Oxycodone Hcl	Oxycodone Hcl	103	44
Levothyroxine Sodium	Levothyroxine Sodium	84	27
Albuterol Sulfate Hfa	Albuterol Sulfate	82	40
Metformin Hcl	Metformin Hcl	78	30
Tamsulosin Hcl	Tamsulosin Hcl	77	24
Pantoprazole Sodium	Pantoprazole Sodium	70	27
Metoprolol Tartrate	Metoprolol Tartrate	69	20
Pregabalin	Pregabalin	65	15
Alendronate Sodium	Alendronate Sodium	64	23
Furosemide	Furosemide	57	23
Duloxetine Hcl	Duloxetine Hcl	55	12
Glipizide	Glipizide	55	21
Simvastatin	Simvastatin	53	19
Mirtazapine	Mirtazapine	52	13
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	49	40
Fluoxetine Hcl	Fluoxetine Hcl	47	15
Valacyclovir	Valacyclovir Hcl	47	13
Methocarbamol	Methocarbamol	46	suppressed
Tramadol Hcl	Tramadol Hcl	46	13
Atenolol	Atenolol	43	15
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	42	15
Alvesco	Ciclesonide	40	12
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	40	11
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	40	18
Metformin Hcl Er	Metformin Hcl	36	15
Omeprazole	Omeprazole	35	15
Citalopram Hbr	Citalopram Hydrobromide	33	11
Escitalopram Oxalate	Escitalopram Oxalate	32	15
Estradiol	Estradiol	32	18
Metoprolol Succinate	Metoprolol Succinate	32	13
Hydrochlorothiazide	Hydrochlorothiazide	30	14
Potassium Chloride	Potassium Chloride	28	12
Quetiapine Fumarate	Quetiapine Fumarate	28	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	25	suppressed
Pradaxa	Dabigatran Etexilate Mesylate	25	suppressed
Sertraline Hcl	Sertraline Hcl	24	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	23	suppressed
Famotidine	Famotidine	22	suppressed
Spiriva Respimat	Tiotropium Bromide	22	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	22	14
Buspirone Hcl	Buspirone Hcl	20	suppressed
Hydrocortisone	Hydrocortisone	20	12
Memantine Hcl	Memantine Hcl	19	suppressed
Pravastatin Sodium	Pravastatin Sodium	19	suppressed
Prednisone	Prednisone	19	12
Acetaminophen-Codeine	Acetaminophen With Codeine	18	suppressed
Latanoprost	Latanoprost	18	suppressed
Bupropion Xl	Bupropion Hcl	17	suppressed
Fluticasone Propionate	Fluticasone Propionate	17	suppressed
Ibuprofen	Ibuprofen	17	suppressed
Naproxen	Naproxen	16	suppressed
Ondansetron Odt	Ondansetron	16	11
Sumatriptan Succinate	Sumatriptan Succinate	16	suppressed
Donepezil Hcl	Donepezil Hcl	15	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	15	suppressed
Lovastatin	Lovastatin	15	suppressed
Bupropion Hcl Sr	Bupropion Hcl	14	suppressed
Humulin N	Insulin Nph Human Isophane	14	suppressed
Meloxicam	Meloxicam	14	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	14	suppressed
Nifedipine Er	Nifedipine	14	suppressed
Nystatin	Nystatin	14	suppressed
Warfarin Sodium	Warfarin Sodium	14	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	14	suppressed
Azelastine Hcl	Azelastine Hcl	13	suppressed
Medroxyprogesterone Acetate	Medroxyprogesterone Acetate	13	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	13	suppressed
Carvedilol	Carvedilol	12	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	12	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	12	suppressed
Lorazepam	Lorazepam	12	12
Bisoprolol Fumarate	Bisoprolol Fumarate	11	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	11	suppressed
Humalog	Insulin Lispro	11	suppressed
Jardiance	Empagliflozin	11	suppressed
Paroxetine Hcl	Paroxetine Hcl	11	suppressed
Primidone	Primidone	11	suppressed
Rivastigmine	Rivastigmine Tartrate	11	suppressed
Spironolactone	Spironolactone	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error